Correlation between bacteriologic and clinical endpoints in trials of acute otitis media.
Johann-Liang
Rosemary
R
Zalkikar
Jyoti
J
Powers
John H
JH
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D024881:Drug Resistance, Bacterial; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D008876:Middle Ear Ventilation / Q000379:methods*; D010033:Otitis Media / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery*; D012008:Recurrence; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents